Screener
Galectin Therapeutics GALT Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.14Miss by $0.05
EPS estimate-$0.09
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.05
Versus estimates
Diluted EPS
FAQ
- When did Galectin Therapeutics report Q2 2026 earnings?
- Galectin Therapeutics (GALT) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Galectin Therapeutics's Q2 2026 revenue and EPS?
- Galectin Therapeutics reported eps of $-0.14 for Q2 2026.
- Did Galectin Therapeutics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.09 by $0.05.
- How did Galectin Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 16.7% from $-0.12.
- Where can I find Galectin Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001140361-26-032946) and the 10-Q periodic report (0001140361-26-032945) directly on SEC EDGAR. The filing index links above go to sec.gov.
